Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
---|---|---|---|---|---|
15.08. | IPO Stock Of The Week: Health Care Leader BrightSpring Eyes Latest Buy Point | 2 | Investor's Business Daily | ||
BRIGHTSPRING HEALTH SERVICES Aktie jetzt für 0€ handeln | |||||
01.08. | BrightSpring raises 2025 adjusted EBITDA guidance to $605M while expanding specialty pharmacy and infusion growth | 1 | Seeking Alpha | ||
01.08. | BrightSpring Health Services, Inc. - 10-Q, Quarterly Report | 2 | SEC Filings | ||
01.08. | BrightSpring Health Services, Inc. Q2 Profit Increases, Beats Estimates | 1 | RTTNews | ||
01.08. | BrightSpring Health Services GAAP EPS of $0.13, revenue of $3.14M | 2 | Seeking Alpha | ||
01.08. | BrightSpring Health Services, Inc. Reports Second Quarter 2025 Financial Results and Increases Full Year 2025 Guidance | 1 | GlobeNewswire (USA) | ||
01.08. | BrightSpring Health Services, Inc. - 8-K, Current Report | - | SEC Filings | ||
31.07. | An Overview of BrightSpring Health's Earnings | 2 | Benzinga.com | ||
08.07. | BrightSpring Health Services, Inc. to Announce Second Quarter 2025 Financial Results on August 1, 2025 | 1 | GlobeNewswire (USA) | ||
01.07. | BrightSpring Health Leads Companies In Line For Triple-Digit Profit Growth | 3 | Investor's Business Daily | ||
26.06. | TD Cowen Begins Coverage of BrightSpring Health Services (BTSG) Stock, Gives Buy | 3 | Insider Monkey | ||
26.06. | BTSG vs. OPCH: Which Home Infusion Stock is a Better Buy Now? | 2 | Zacks | ||
25.06. | BTSG Raises 2025 Financial Outlook: What's Backing It? | 3 | Zacks | ||
23.06. | TD Cowen stuft BrightSpring Health mit "Kaufen" ein | 3 | Investing.com Deutsch | ||
23.06. | BrightSpring Health stock initiated with Buy rating at TD Cowen | 1 | Investing.com | ||
20.06. | BrightSpring Health Services, Inc. - 8-K, Current Report | 1 | SEC Filings | ||
20.06. | Can BrightSpring's Q1 Strength Carry Through 2025 Headwinds? | 3 | Zacks | ||
18.06. | BrightSpring's Onco360 als Apotheken-Partner für Krebstherapien ausgewählt | 5 | Investing.com Deutsch | ||
18.06. | BrightSpring's Onco360 selected as pharmacy partner for cancer therapies | 2 | Investing.com | ||
18.06. | BrightSpring Health Services, Inc.: BrightSpring Health Services Announces Onco360 Selected as National Pharmacy Partner for Multiple New Cancer and Rare Disease Drugs | 4 | GlobeNewswire (USA) |
Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten | ||
---|---|---|---|---|---|
UNITEDHEALTH | 265,45 | +0,08 % | wO Börsenlounge: Apple | Porsche | DroneShield - Hat Warren Buffett UnitedHealth zu früh gekauft? | Laut Bloomberg hat das US-Justizministerium seine Ermittlungen ausgeweitet. Im Fokus stehen mögliche Unregelmäßigkeiten bei der Rezeptverwaltung und Vergütung von Ärzten. Hat Warren Buffett zu früh... ► Artikel lesen | |
MEDTRONIC | 80,00 | -0,21 % | Medtronic erhält grünes Licht für erweitertes Diabetes-System in den USA | Das US-amerikanische Gesundheitsunternehmen Medtronic hat von der Food and Drug Administration (FDA) zwei wichtige Zulassungen für sein MiniMed-780G-System erhalten. Damit erweitert der Konzern die... ► Artikel lesen | |
INTUITIVE SURGICAL | 402,15 | -0,19 % | BRISANTE Meldung setzt Intuitive Surgical Aktionäre unter Zugzwang. Bitte reagieren Sie jetzt sofort! | ||
THERMO FISHER | 417,15 | -0,37 % | Solventum Completes Sale of its Purification & Filtration Business to Thermo Fisher Scientific Inc. | Accelerates Solventum's business transformation to deliver long-term shareholder value
Net proceeds will be used primarily to pay down debt
ST. PAUL, Minn.... ► Artikel lesen | |
ROKU | 81,97 | -0,51 % | Cathie Wood's ARK ETF adjusts holdings, buys CRISPR and sells Roku | ||
HIMS & HERS HEALTH | 35,850 | +0,36 % | HIMS' Personalized Wellness Platform Expands Preventive Care Access | ||
BECTON DICKINSON | 162,70 | +0,68 % | Becton, Dickinson and Company (BDX) Generated Lower-Than-Expected Revenue in Q2 | ||
DEXCOM | 64,14 | +0,49 % | Marvell Technology, eBay, And DexCom Are Among Top 10 Large Cap Losers Last Week (August 25-August 29): Are The Others In Your Portfolio? | ||
RESMED | 233,30 | +0,26 % | Resmed, Inc.: Obstructive Sleep Apnea Expected to Affect Nearly 77 million U.S. Adults by 2050, New Resmed Study Finds | Published in The Lancet Respiratory Medicine, research reveals sharp rise in OSA, especially among women, highlighting the need for earlier diagnosis, preventative strategies, and personalized careSAN... ► Artikel lesen | |
DAVITA | 116,75 | -0,72 % | DaVita Inc. Q2 Sales Increase | WASHINGTON (dpa-AFX) - DaVita Inc. (DVA) revealed a profit for second quarter of $199.34 millionThe company's bottom line totaled $199.34 million, or $2.58 per share. This compares with $222.68... ► Artikel lesen | |
ATOSSA THERAPEUTICS | 0,648 | -1,82 % | RedChip Companies, Inc.: NioCorp and Atossa Therapeutics Interviews to Air on the RedChip Small Stocks, Big Money Show on Bloomberg TV | ORLANDO, FL / ACCESS Newswire / August 29, 2025 / RedChip Companies will air interviews with NioCorp Developments Ltd. (Nasdaq:NB) and Atossa Therapeutics, Inc. (Nasdaq:ATOS) on the RedChip Small Stocks... ► Artikel lesen | |
GE HEALTHCARE TECHNOLOGIES | 61,51 | -0,02 % | GE HealthCare Technologies-Aktie: Kurs fällt ab (61,4384 €) | Am US-amerikanischen Aktienmarkt notiert das Wertpapier von GE HealthCare Technologies derzeit etwas leichter. Der jüngste Kurs betrug 71,47 US-Dollar. Heute hat sich im US-amerikanischen Wertpapierhandel... ► Artikel lesen | |
EVOFEM BIOSCIENCES | - | - | Evofem Biosciences, Inc.: Evofem Reports Positive Financial Results for Second Quarter of 2025, Provides Business Update | -- Increased Net Sales and Improved Loss from Operations in Q2 2025 vs. Prior Year Quarter --
-- Evofem Advances Plans for Special Meeting of Stockholders to Approve... ► Artikel lesen | |
ORGANON | 8,016 | -0,89 % | Organon and Henlius get FDA nod for Amgen biosimilars | ||
CENTENE | 25,345 | -0,33 % | Are Strategic Contracts and Partnerships Centene's Growth Engine? |